Gilead Sciences (GILD) Revenue — Quarter Ended Dec 31, 2023
Revenue for the quarter was essentially flat compared to the prior quarter, while declining versus the same quarter one year earlier.
Key takeaway
Quarter ended Dec 31, 2023 · FY2023 Q4
Revenue for the quarter was essentially flat compared to the prior quarter, while declining versus the same quarter one year earlier.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$7.1B
Revenue reported for this quarter.
Quarter-over-quarter
+0.9%
Change from the immediately preceding quarter.
Year-over-year
-3.7%
Change from the comparable year-ago quarter.
Trailing four quarters
$27.1B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2023 | $6.4B | -3.6% |
| Jun 30, 2023 | $6.6B | +5.4% |
| Sep 30, 2023 | $7.1B | +0.1% |
| Dec 31, 2023 | $7.1B | -3.7% |
Revenue performance
Sequential revenue showed a slight increase, but year-over-year revenue declined.
Quarterly comparison
Compared to the immediately preceding quarter, revenue increased modestly. Compared to the same quarter last year, revenue decreased.
What to watch
Monitor whether the year-over-year revenue decline persists in future quarters.